Loading ...
Sorry, an error occurred while loading the content.

OT: Epogen recall - safety alert

Expand Messages
  • carolroar@aol.com
    I know that many here also have CRF kitties, so please if you give your kitties Epogen or Procrit, check your supply. Carol http://tinyurl.com/28dfv2q Epogen
    Message 1 of 1 , Sep 27 1:28 AM
    • 0 Attachment
      I know that many here also have CRF kitties, so please if you give your kitties Epogen or Procrit, check your supply.

      Carol

      http://tinyurl.com/28dfv2q
      Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials
      [Posted 09/24/2010]
      AUDIENCE: Risk Manager, Oncology, Nephrology
      ISSUE: Amgen and FDA notified healthcare professionals that certain lots of Epogen and Procrit (Epoetin alfa) vials are being recalled as a precaution, because the vials may contain extremely thin glass flakes (lamellae) that are barely visible. The potential serious adverse events resulting from the use of a sterile injectable product with particulates by the intravenous route include embolic, thrombotic and other vascular events (e.g., phlebitis), and by the subcutaneous route include foreign body granuloma, local injection site reactions, and increased immunogenicity.
      BACKGROUND: The products are indicated for the treatment of anemia related to HIV therapy, chronic renal failure, and chemotherapy. The lamellae result from the interaction of the formulation with glass vials over the shelf life of the product. The affected product lot numbers and expiration dates are included in the table in the firm press release, linked below.
      RECOMMENDATIONS: Amgen has initiated recall letters which include instructions to return the referenced product to the returned goods service provider.
      Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to 1-800-77-AMGEN or to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

      Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
      Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


      [09/24/2010 - Press Release - FDA]


      [Posted 09/24/2010]
      AUDIENCE: Risk Manager, Oncology, Nephrology
      ISSUE: Amgen and FDA notified healthcare professionals that certain lots of Epogen and Procrit (Epoetin alfa) vials are being recalled as a precaution, because the vials may contain extremely thin glass flakes (lamellae) that are barely visible. The potential serious adverse events resulting from the use of a sterile injectable product with particulates by the intravenous route include embolic, thrombotic and other vascular events (e.g., phlebitis), and by the subcutaneous route include foreign body granuloma, local injection site reactions, and increased immunogenicity.
      BACKGROUND: The products are indicated for the treatment of anemia related to HIV therapy, chronic renal failure, and chemotherapy. The lamellae result from the interaction of the formulation with glass vials over the shelf life of the product. The affected product lot numbers and expiration dates are included in the table in the firm press release, linked below.
      RECOMMENDATIONS: Amgen has initiated recall letters which include instructions to return the referenced product to the returned goods service provider.
      Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to 1-800-77-AMGEN or to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

      Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
      Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


      [09/24/2010 - Press Release - FDA]




      [Non-text portions of this message have been removed]
    Your message has been successfully submitted and would be delivered to recipients shortly.